Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200569146> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4200569146 endingPage "2169" @default.
- W4200569146 startingPage "2164" @default.
- W4200569146 abstract "Objective: To evaluate the detection of MDR-TB and XDR-TB patients and to provide evidence for further improvement of MDR-TB and XDR-TB screening strategy. Methods: Patients who were under drug resistance surveillance, registered and reported by the TB Management Information System of the Chinese Disease Prevention and Control Information System from 2012 to 2019 and resided in Guizhou province were retrospectively analyzed. The contribution of five high-risk subgroups to detection of MDR/XDR-TB were evaluated using population attributable risk proportion (PARP). Results: Of the 18 506 cases under drug resistance surveillance, patients who were male, aged between 25 and 54 years, with drug-resistant TB or with MDR/XDR-TB accounted for 68.65% (12 705/18 506), 47.69% (8 826/18 506), 15.90% (2 943/18 506) or 5.42% (1 003/18 506), respectively. Five high-risk subgroups made significant contributions to the detection of MDR/XDR-TB with a PARP of 57.00%. Specifically, the PARP were 21.70%, 19.49%, 11.90% and 2.30% for patients that were relapse and return, failed initial treatment, chronic/retreatment failure and smear-positive at the end of the second or third month, respectively. The detection rate of MDR/XDR-TB in high-risk groups was 15.89% (578/3 637) while in low-risk groups was 2.86% (425/14 869). Conclusions: Number of patients under drug resistance surveillance and the detection of MDR/XDR-TB trended to increase in Guizhou province from 2012 to 2019. The detection rate of MDR/XDR-TB in high-risk groups was higher than low-risk groups.目的： 评价贵州省肺结核患者中的耐多药/广泛耐药结核病（MDR/XDR-TB）发现情况，为进一步优化筛查策略提供科学依据。 方法： 对贵州省2012-2019年中国疾病预防控制信息系统“结核病管理信息系统”登记报告的耐药监测肺结核病例进行回顾性分析，采用人群归因危险度百分比（PARP）评估不同耐药风险患者对MDR/XDR-TB发现的贡献。 结果： 在18 506例开展耐药筛查的病例中，男性占68.65%（12 705/18 506），25~54岁占47.69%（8 826/18 506），耐药患者占15.90%（2 943/18 506），MDR/XDR-TB占5.42%（1 003/18 506）。在发现的所有MDR/XDR-TB患者中，耐药高风险人群对病例发现的贡献占一半以上（PARP=57.00%），而不同类别的耐药高风险人群对MDR/XDR-TB发现的贡献不同，其中复发和返回、初治失败、慢性患者/复治失败和2/3个月末痰片涂阳的PARP分别为21.70%、19.49%、11.90%和2.30%。耐药高风险人群中MDR/XDR-TB检出率为15.89%（578/3 637），低风险人群中MDR/XDR-TB检出率为2.86%（425/14 869），差异有统计学意义（P<0.001）。 结论： 贵州省耐药监测力度及MDR/XDR-TB病例发现水平总体处于上升态势，耐药高风险人群中MDR/XDR-TB的检出率高于低风险人群。." @default.
- W4200569146 created "2021-12-31" @default.
- W4200569146 creator A5018008882 @default.
- W4200569146 creator A5020777804 @default.
- W4200569146 creator A5036151138 @default.
- W4200569146 creator A5043913740 @default.
- W4200569146 creator A5053796862 @default.
- W4200569146 date "2021-12-10" @default.
- W4200569146 modified "2023-09-26" @default.
- W4200569146 title "[Evaluation of screening strategies of multidrug-resistant tuberculosis among pulmonary tuberculosis patients of the different risk levels]." @default.
- W4200569146 doi "https://doi.org/10.3760/cma.j.cn112338-20210125-00063" @default.
- W4200569146 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34954981" @default.
- W4200569146 hasPublicationYear "2021" @default.
- W4200569146 type Work @default.
- W4200569146 citedByCount "1" @default.
- W4200569146 countsByYear W42005691462022 @default.
- W4200569146 crossrefType "journal-article" @default.
- W4200569146 hasAuthorship W4200569146A5018008882 @default.
- W4200569146 hasAuthorship W4200569146A5020777804 @default.
- W4200569146 hasAuthorship W4200569146A5036151138 @default.
- W4200569146 hasAuthorship W4200569146A5043913740 @default.
- W4200569146 hasAuthorship W4200569146A5053796862 @default.
- W4200569146 hasConcept C114851261 @default.
- W4200569146 hasConcept C126322002 @default.
- W4200569146 hasConcept C133936738 @default.
- W4200569146 hasConcept C142724271 @default.
- W4200569146 hasConcept C2777107064 @default.
- W4200569146 hasConcept C2777975735 @default.
- W4200569146 hasConcept C2781069245 @default.
- W4200569146 hasConcept C2908647359 @default.
- W4200569146 hasConcept C71924100 @default.
- W4200569146 hasConcept C86803240 @default.
- W4200569146 hasConcept C89423630 @default.
- W4200569146 hasConcept C99454951 @default.
- W4200569146 hasConceptScore W4200569146C114851261 @default.
- W4200569146 hasConceptScore W4200569146C126322002 @default.
- W4200569146 hasConceptScore W4200569146C133936738 @default.
- W4200569146 hasConceptScore W4200569146C142724271 @default.
- W4200569146 hasConceptScore W4200569146C2777107064 @default.
- W4200569146 hasConceptScore W4200569146C2777975735 @default.
- W4200569146 hasConceptScore W4200569146C2781069245 @default.
- W4200569146 hasConceptScore W4200569146C2908647359 @default.
- W4200569146 hasConceptScore W4200569146C71924100 @default.
- W4200569146 hasConceptScore W4200569146C86803240 @default.
- W4200569146 hasConceptScore W4200569146C89423630 @default.
- W4200569146 hasConceptScore W4200569146C99454951 @default.
- W4200569146 hasIssue "12" @default.
- W4200569146 hasLocation W42005691461 @default.
- W4200569146 hasOpenAccess W4200569146 @default.
- W4200569146 hasPrimaryLocation W42005691461 @default.
- W4200569146 hasRelatedWork W13054867 @default.
- W4200569146 hasRelatedWork W1360614 @default.
- W4200569146 hasRelatedWork W16128866 @default.
- W4200569146 hasRelatedWork W1803831 @default.
- W4200569146 hasRelatedWork W3778371 @default.
- W4200569146 hasRelatedWork W4573516 @default.
- W4200569146 hasRelatedWork W832665 @default.
- W4200569146 hasRelatedWork W9102923 @default.
- W4200569146 hasRelatedWork W9161028 @default.
- W4200569146 hasRelatedWork W9266431 @default.
- W4200569146 hasVolume "42" @default.
- W4200569146 isParatext "false" @default.
- W4200569146 isRetracted "false" @default.
- W4200569146 workType "article" @default.